Catalyst Biosciences

Catalyst Biosciences is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases.

Catalyst Biosciences is a drug discovery and development company. It is creating novel catalytic biopharmaceutical products based on engineered human proteases. The mission is to establish protease therapeutics as a new therapeutic platform comparable in depth and scope to antibody pharmaceuticals. The Company is developing proteases for the treatment of a broad range of diseases with a strong focus on hemostasis and inflammation. The Company's product discovery platform is based on methods to rapidly create and characterize tailor-made protease drug candidates, called Alteraseâ„¢ therapeutics, that cleave disease-causing proteins or improve the biochemical and pharmacological properties of marketed protease drugs.